Financial Performance - The company reported a basic earnings per share of 0.6700 yuan for 2024, a significant increase of 115.91% compared to a loss of 4.2100 yuan in 2023 [1] - The net profit for 2024 was 5.79 billion yuan, recovering from a loss of 36.51 billion yuan in 2023, marking a 115.86% improvement [1] - Operating revenue decreased to 87.63 billion yuan in 2024, down 54.96% from 194.58 billion yuan in 2023 [1] - The net asset return rate was not reported for 2024, but it was -49.79% in 2022 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 91,766.53 million shares, accounting for 62.52% of the circulating shares, with an increase of 60,495.80 million shares compared to the previous period [1] - New significant shareholders include Fujian Aonong Biotechnology Group Co., Ltd. with 47,941.08 million shares (32.66% of total shares) and Xinyang Bank with 8,665.81 million shares (5.90% of total shares) [2] - Notable exits from the top ten shareholders include Huang Zuyiao and Cen Yetao, who have withdrawn from the list [2] Dividend Distribution - The company has announced no distribution or capital increase for the current period [3]
*ST傲农:2024年报净利润5.79亿 同比增长115.86%
Tong Hua Shun Cai Bao·2025-04-29 09:57